Sessions Were Renumbered as of May 19.
Legend:
CC-W = McCormick Place Convention Center, West Building,
CC-N = McCormick Place Convention Center, North Building
H = Hilton Chicago,
UC = Conference Chicago at University Center
* = applied session ! = JSM meeting theme
660 * !
Thu, 8/4/2016,
8:30 AM -
10:20 AM
CC-W184a
Deep Dive: Exploring Testing Procedures in the Biopharmaceutical Statistician's Toolbox — Contributed Papers
Biopharmaceutical Section , Royal Statistical Society
Chair(s): Thomas Kelleher, Bristol-Myers Squibb
8:35 AM
Efficient Study Designs in Clinical Research
—
Steven Julious, University of Sheffield
8:50 AM
Statistical Testing in the Presence of Nonproportional Hazards
—
Amarjot Kaur, Merck ; Yabing Mai, Merck Research Laboratories ; Ziliang Li, MRL ; Xia Xu, MRL ; Wen-Chi Wu, MRL
9:05 AM
The Impact of Sensitivity and Specificity of Case Definition on Vaccine Efficacy Trial Design
—
Xiaohua Sheng, Sanofi Pasteur ; Steven Self, Fred Hutchinson Cancer Research Center ; Ehab Bassily, Sanofi Pasteur ; Joshua Chen, Sanofi Pasteur
9:20 AM
Evaluation of Logistic and Cox Regression Models Using Simulated Survival Data and Clinical Practice Research Datalink
—
Jessica Kim , FDA ; Chenyi Pan, University of Virginia ; Clara Y. Kim, FDA/CDER ; Esther Zhou, FDA/CDER
9:35 AM
Challenges in Disease Prevention Studies That Utilize Continuous Diagnostic Endpoints
—
Norman Bohidar, Johnson & Johnson ; George Capuano, Johnson & Johnson
9:50 AM
Why the Likelihood Ratio Test Is Inappropriate to Test Dose-Response and Sharing of Information Among Antibody Therapies for Dose Selection
—
Russell Reeve, Quintiles
10:05 AM
Asymmetric Margins for Equivalence Tests
—
Somesh Chattopadhyay
